Select interviews from the 2011 San Antonio Breast Cancer Symposium (SABCS) and American Society of Hematology (ASH) Annual Meeting

Oncology (Williston Park). 2011 Dec;25(14):1422-4, 1426.
No abstract available

Publication types

  • Interview
  • Portrait

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bleomycin / administration & dosage
  • Breast Neoplasms / diagnosis
  • Breast Neoplasms / drug therapy*
  • Cyclophosphamide / administration & dosage
  • Dacarbazine / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Fertility Preservation
  • Humans
  • Lapatinib
  • Lymphoma / complications
  • Lymphoma / diagnosis
  • Lymphoma / drug therapy*
  • Molecular Targeted Therapy
  • Prednisone / administration & dosage
  • Pregnancy
  • Pregnancy Complications, Neoplastic / diagnosis
  • Pregnancy Complications, Neoplastic / drug therapy*
  • Pregnancy Outcome
  • Quinazolines / administration & dosage
  • Receptor, ErbB-2 / antagonists & inhibitors
  • Rituximab
  • Trastuzumab
  • Vinblastine / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal, Humanized
  • Antibodies, Monoclonal, Murine-Derived
  • Quinazolines
  • Lapatinib
  • Bleomycin
  • Rituximab
  • Vincristine
  • Vinblastine
  • Dacarbazine
  • Doxorubicin
  • Cyclophosphamide
  • Receptor, ErbB-2
  • pertuzumab
  • Trastuzumab
  • Prednisone

Supplementary concepts

  • ABVD protocol
  • CHOP protocol